Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (303)
Allogene Therapeutics, Inc. (ALLO)
Beneski Benjamin Machinas — SVP, Chief Technical Officer
Shares
2,867
Price
$2.50
Total Value
$7.17K
Shares Held After
195,338
% of Holdings
1.4%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
453
Price
$27.05
Total Value
$12.25K
Shares Held After
705,051
% of Holdings
0.1%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
55,183
Price
$26.54
Total Value
$1.46M
Shares Held After
705,504
% of Holdings
7.3%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
19,364
Price
$25.50
Total Value
$493.79K
Shares Held After
760,687
% of Holdings
2.5%
Processa Pharmaceuticals, Inc. (PCSA)
Neal James R — Director
Shares
789
Price
$2.54
Total Value
$2.00K
Shares Held After
818
% of Holdings
96.5%
Zenas BioPharma, Inc. (ZBIO)
Lu Hongbo — Director
Shares
3,768
Price
$18.63
Total Value
$70.20K
Shares Held After
426,736
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$594.11
Total Value
$118.82K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
700
Price
$593.13
Total Value
$415.19K
Shares Held After
40,713
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$590.36
Total Value
$448.67K
Shares Held After
41,413
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$589.40
Total Value
$353.64K
Shares Held After
42,173
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
567
Price
$588.38
Total Value
$333.61K
Shares Held After
42,773
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
467
Price
$587.37
Total Value
$274.30K
Shares Held After
43,340
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
886
Price
$586.14
Total Value
$519.32K
Shares Held After
43,807
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,161
Price
$585.00
Total Value
$679.18K
Shares Held After
44,693
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
980
Price
$584.04
Total Value
$572.36K
Shares Held After
45,854
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,391
Price
$583.08
Total Value
$811.06K
Shares Held After
46,834
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
805
Price
$582.19
Total Value
$468.67K
Shares Held After
48,225
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
503
Price
$581.10
Total Value
$292.29K
Shares Held After
49,030
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$580.08
Total Value
$139.22K
Shares Held After
49,533
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$577.54
Total Value
$92.41K
Shares Held After
49,773
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$574.55
Total Value
$45.96K
Shares Held After
49,933
% of Holdings
0.2%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
675
Price
$110.83
Total Value
$74.81K
Shares Held After
6,760
% of Holdings
9.1%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
2,325
Price
$110.11
Total Value
$256.00K
Shares Held After
7,435
% of Holdings
23.8%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
520
Price
$10.60
Total Value
$5.51K
Shares Held After
1,538,296
% of Holdings
0.0%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Sabar Karimah Es — Director
Shares
61,265
Price
$30.17
Total Value
$1.85M
Shares Held After
0
% of Holdings
100.0%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Krasney Karen — EVP, GENERAL COUNSEL
Shares
25,000
Price
$30.12
Total Value
$752.93K
Shares Held After
30,547
% of Holdings
45.0%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Bergmann Anthony — CHIEF FINANCIAL OFFICER
Shares
25,000
Price
$30.13
Total Value
$753.15K
Shares Held After
8,223
% of Holdings
75.2%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
7,600
Price
$85.38
Total Value
$648.88K
Shares Held After
61,202
% of Holdings
11.0%
Kymera Therapeutics, Inc. (KYMR)
Ridloff Elena — Director
Shares
7,400
Price
$85.37
Total Value
$631.74K
Shares Held After
0
% of Holdings
100.0%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
25,000
Price
$22.76
Total Value
$569.09K
Shares Held After
986,667
% of Holdings
2.5%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,854
Price
$2.54
Total Value
$4.70K
Shares Held After
3,110
% of Holdings
59.6%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,136
Price
$2.54
Total Value
$5.41K
Shares Held After
3,649
% of Holdings
58.5%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,603
Price
$2.54
Total Value
$4.06K
Shares Held After
3,356
% of Holdings
47.8%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,810
Price
$2.54
Total Value
$4.59K
Shares Held After
10,562
% of Holdings
17.1%
Processa Pharmaceuticals, Inc. (PCSA)
Pannu Geraldine — Director
Shares
2,072
Price
$2.54
Total Value
$5.25K
Shares Held After
2,188
% of Holdings
94.7%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
7,232
Price
$85.54
Total Value
$618.63K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
19,469
Price
$84.57
Total Value
$1.65M
Shares Held After
7,232
% of Holdings
72.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
59,800
Price
$83.90
Total Value
$5.02M
Shares Held After
26,701
% of Holdings
69.1%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
2,366
Price
$82.84
Total Value
$196.00K
Shares Held After
86,501
% of Holdings
2.7%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
800
Price
$81.36
Total Value
$65.09K
Shares Held After
88,867
% of Holdings
0.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
1,485
Price
$80.25
Total Value
$119.17K
Shares Held After
89,667
% of Holdings
1.6%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
21,825
Price
$78.86
Total Value
$1.72M
Shares Held After
91,152
% of Holdings
19.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
1,390
Price
$78.33
Total Value
$108.88K
Shares Held After
112,977
% of Holdings
1.2%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,324
Price
$2.54
Total Value
$5.89K
Shares Held After
2,324
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Soteropoulos Paula — Director
Shares
599
Price
$80.11
Total Value
$47.99K
Shares Held After
0
% of Holdings
100.0%
Processa Pharmaceuticals, Inc. (PCSA)
Baluch Khoso — Director
Shares
2,269
Price
$2.54
Total Value
$5.75K
Shares Held After
2,325
% of Holdings
97.6%
Processa Pharmaceuticals, Inc. (PCSA)
Bigora Sian — Chief Development Officer
Shares
2,107
Price
$2.54
Total Value
$5.34K
Shares Held After
3,711
% of Holdings
56.8%
Polyrizon Ltd. (PLRZ)
Adler Oz — Director
Shares
3,292
Price
$12.05
Total Value
$39.67K
Shares Held After
19,850
% of Holdings
14.2%
Polyrizon Ltd. (PLRZ)
Carmel Liron — Director
Shares
942
Price
$12.36
Total Value
$11.64K
Shares Held After
3,127
% of Holdings
23.2%
Polyrizon Ltd. (PLRZ)
Izraeli Tomer — Director
Shares
500
Price
$11.85
Total Value
$5.92K
Shares Held After
31,512
% of Holdings
1.6%
Showing 101–150 of 303 transactions (page 3 of 7)